Prof Behjati is a Group Leader at the Wellcome Sanger Institute and Consultant Paediatric Oncologist at Addenbrooke’s Hospital, Cambridge. His research is focused on unravelling the origins of cancer, using a variety of cutting edge nucleic acid sequencing technologies. Previously he has defined the somatic genetic basis of different subtypes of sarcoma, as part of the UK contribution to the International Cancer Genome Consortium. He continues to pursue his interest in sarcoma genomics through the Genomics England sarcoma programme and his own research. Prof Behjati read medicine at the University of Oxford and pursued clinical academic training in paediatric oncology in London and Cambridge.
As our Grant Review Panel Chair, Sam also sits on our Research Strategy Committee to guide the overall direction of research funding at Sarcoma UK.